Literature DB >> 18502707

Quantitative evaluation of sphingomyelin and glucosylceramide using matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to tissues from patients with Niemann-Pick disease types A and C, and Gaucher disease.

Takehisa Fujiwaki1, Masaru Tasaka, Seiji Yamaguchi.   

Abstract

Niemann-Pick disease types A and C, and Gaucher disease are glycolipid storage disorders characterized by the systemic deposition of glycosphingolipids, i.e., sphingomyelin in Niemann-Pick disease types A and C tissues and glucosylceramide in Gaucher disease ones, respectively. Using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF/MS), we analyzed the sphingolipids in liver and spleen specimens from patients with Niemann-Pick disease types A and C, and Gaucher disease. Crude lipids were extracted from tissue containing 5mg protein with chloroform and methanol. After mild alkaline treatment of the crude lipids, a sphingolipid fraction was prepared and analyzed by MALDI-TOF/MS. The results were as follows: (a) ion peaks with m/z values corresponding to different sphingomyelin and ceramide monohexoside (CMH) species were clearly detected. (b) With sphingosylphosphorylcholine as the internal standard for quantification of sphingomyelin and CMH, the relative peak heights of sphingomyelin and CMH were calculated and plotted versus their contents. The relative peak heights of sphingomyelin and CMH showed linearity between 50 and 1500 ng sphingomyelin content, and between 5 and 150 ng CMH content, respectively. (c) Quantitative analysis revealed the accumulation of sphingomyelin in the liver and spleen specimens from the patients with Niemann-Pick disease types A and C. Striking accumulation of CMH was also detected in the liver and spleen specimens from the patients with Gaucher disease. This investigation indicated that accumulated sphingomyelin and CMH in small amounts of tissues from sphingolipidosis patients can be detected quantatively with the MALDI-TOF/MS method. This method will be useful not only for the diagnosis but also for biochemical pathophysiology evaluation of patients with various sphingolipidosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502707     DOI: 10.1016/j.jchromb.2008.05.013

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Considerations for quantification of lipids in nerve tissue using matrix-assisted laser desorption/ionization mass spectrometric imaging.

Authors:  Rachelle R Landgraf; Timothy J Garrett; Maria C Prieto Conaway; Nigel A Calcutt; Peter W Stacpoole; Richard A Yost
Journal:  Rapid Commun Mass Spectrom       Date:  2011-10-30       Impact factor: 2.419

Review 2.  Quantitative matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  Mark W Duncan; Heinrich Roder; Stephen W Hunsucker
Journal:  Brief Funct Genomic Proteomic       Date:  2008-09

Review 3.  Desorption electrospray ionization mass spectrometry for lipid characterization and biological tissue imaging.

Authors:  Livia S Eberlin; Christina R Ferreira; Allison L Dill; Demian R Ifa; R Graham Cooks
Journal:  Biochim Biophys Acta       Date:  2011-05-27

4.  Lithium Hydroxide Hydrolysis Combined with MALDI TOF Mass Spectrometry for Rapid Sphingolipid Detection.

Authors:  Anh Tran; Liting Wan; Zhenbo Xu; Janette M Haro; Bing Li; Jace W Jones
Journal:  J Am Soc Mass Spectrom       Date:  2020-10-30       Impact factor: 3.109

5.  Lipidomics of glycosphingolipids.

Authors:  Hany Farwanah; Thomas Kolter
Journal:  Metabolites       Date:  2012-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.